Ikeuchi, Emina
Kuroda, Daisuke
Nakakido, Makoto
Murakami, Akikazu
Tsumoto, Kouhei
Funding for this research was provided by:
Okawa Foundation for Information and Telecommunications (20-10)
Japan Society for the Promotion of Science (JP19H04202, JP16H02420, JP19H05766, JP20H02531)
Japan Agency for Medical Research and Development (JP20wm0325002s, JP19ak0101117h, JP20ak0101139h, JP18ak0101100h, JP18am0101094j, JP18dm0107064h, JP18mk0101081h, JP18fm0208030h, JP18fk0108073h, JP18ak0101100h)
Japan Science and Technology Agency (JPMJCR20H8)
Article History
Received: 23 December 2020
Accepted: 8 September 2021
First Online: 18 October 2021
Competing interests
: The Panasonic Corporation provided support in the form of salaries for E.I. The Panasonic Corporation has also filed a patent application that refers to the antibodies used in this study (16/372506, 2018-110552). This does not alter our adherence to the policies of the journal on sharing data and materials. The other authors declare no potential conflict of interest.